dr. Nina Zidar Institute ofPathology FacultyofMedicine ... · dr. Nina Zidar Institute ofPathology...
Transcript of dr. Nina Zidar Institute ofPathology FacultyofMedicine ... · dr. Nina Zidar Institute ofPathology...
Early oesophageal cancer
dr. Nina Zidar
Institute of Pathology
Faculty of Medicine
University of Ljubljana
Slovenia
Early carcinoma of oesophagus = tumor limited
to mucosa or submucosa, not extending into
muscularis propria.
• T1a: tumors invading lamina propria or
muscularis mucosae
• T1b: tumors invading submucosa
AJCC (American Joint Comittee on
Cancer) TNM Classification
Risk of lymph node metastases in GI tract
depending on the depth of invasion
Depth of
infiltration
Colon Stomach Oesophagus
Mucosa 0 2 – 4 % 2 – 3 %
Submucosa 3 – 18 % 12 – 27 % 30 – 52 %
Vieth M and Stolte M. Pathology of the early upper GI cancer. Best
Pract Res Clin Gastroenterol 2005; 19: 857-69
Staging T1 carcinoma of oesophagus
M1 = in situ carcinoma
M2 = invasion of lamina propria
M3 = invasion to musc. mucosae
SM1 = invasion of upper third of submucosa
SM2 = invasion of middle thirdof submucosa
SM3 = invasion of lower third ofsubmucosa
• Endo M and Kawano T. Detection and classification of early esophageal squamous cell cancer. Dis
Esophagus 1997; 10: 155-8
• Eguchi T et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for
esophageal cancer. Mod Pathol 2006; 19: 475-80
Early carcinoma of oesophagus
Early SCC ≠ early adenocarcinoma!
- epidemiology
- etiology
- behaviour
- prognosis
1. EPIDEMIOLOGY
Epidemiology of oesophageal carcinoma
• worldwide SCC predominates
• Western world: adenocarcinoma replaced SCC
• 6-fold increase in incidence of adenocarcinoma
• mild decline of SCC
• adenocarcinoma: the most rapidly increasing ca
• SCC rarely diagnosed at early stage
• adenocarcinoma may be detected early (endoscopic
surveillance of Barrett‘s)
2. ETIOPATHOGENESIS
Etiology of oesophageal squamous cell
carcinoma
• tobacco and alcohol
• diet
• genetic factors
• radiation
• achalasia
• inflammatory conditions (gastritis, coeliac
disease, systemic sclerosis, caustic injury)
• history of ca of the upper aerodigestive tract
• infection (aspergillus, candida, HPV)
Etiology of oesophageal squamous cell
carcinoma
• extensive genetic damage - field cancerization
• high risk for developing a second primary tumor
(prevalence of 9%)
• synchronous carcinoma: diagnosed within 6 months
after the index tumor
• metachronous carcinoma: diagnosed more than 6
months after the index tumor
• pharyngeal or oral SCC →risk for esophageal SCC
Slaughter et al. »Field cancerization« in oral stratified squamous epithelium: clinical
implication of multicentric origin. Cancer 1953; 6: 963-8
HPV in squamous cell carcinoma of oesophagus
In situ hybr. E6/E7 mRNA
• conflicting results
• prevalence of HVP from 0% to 70%
• HPV may potentially be involved in
oesophageal cancerogenesis
• use proper methods to
demonstrate transcriptionally active
(integrated) virus
p16
Al-Haddad S et al. Infection and esophageal cancer. Ann N Y Acad Sci 2014;
1325: 187-96
Etiology of oesophageal adenocarcinoma
• Barrett oesophagus (95% of adenocarcinomas)
• gastro-oesophageal reflux disease (GERB)
• tobacco and alcohol
• obesity
• dietary factors
• inversely associated with H pylori gastritis
• HPV?
• rarely from submucosal glands and gastric
heterotopia
HPV in adenocarcinoma of oesophagus
Rajendra S et al. Transcriptionally active human papillomavirus is strongly associated with
Barrett‘s dysplasia and esophageal adenocarcinoma. Am J Gastroenterol 2013; 108: 1082
HPV may be involved in oesophageal adenocarcinoma:
• p16, PCR, E6/E7 mRNA: high viral load in Barrett with
dysplasia or carcinoma,
• but not in Barrett without dysplasia and in controls
4. MACROSCOPICAL FEATURES
Carcinoma of oesophagus
• SCC: middle third
• adenocarcinoma: lower
third
Squamous cell carcinoma of oesophagus
pT2pT1 pT3
Adenocarcinoma in Barrett‘s oesophagus
5. MICROSCOPICAL FEATURES
Squamous cell carcinoma of oesophagus
Grade 2Grade 1 Grade 3
Squamous cell carcinoma
Cytokeratin 5/6
Squamous cell carcinoma
p63
Oesophageal squamous cell carcinoma –
differential diagnosis
• dysplasia (intraepithelial neoplasia)
• invasion beyond the basement membrane
• desmoplasia
• no ancillary methods
• serial sections!!
• metastases and direct spread (from lungs)
Adenocarcinoma of oesophagus
Intestinal, well differentiated Intestinal, poorly differentiated
Adenocarcinoma of oesophagus
Diffuse type (signet ring) Mucinous (colloid)
Oesophageal adenocarcinoma –
differential diagnosis
• dysplasia (no nucleoli, no necrosis, no back-
to-back glands)
• stomach carcinoma infiltrating oesophagus
• CK7+ CK20±, CDX2±, mostly TTF1 -
• metastases and direct spread from lungs
(TTF1+)
Duplicated muscularis mucosae in
Barrett‘s oesophagus
Duplicated muscularis mucosae(musculo-fibrous anomaly)
Rubio CA, Riddell R. Musculo-fibrous anomaly in
Barrett's mucosa with dysplasia. Am J Surg
Pathol 1988; 12: 885-9
• thickening of muscularismucosae, fibrosis, extension to lamina propria
• similar than in urinary bladdercarcinoma
• specific for Barrett‘s oesophagus(50%-100%)
• not related to dysplasia or carcinoma
• may result in erroneous stagingof carcinoma
Duplicated muscularis mucosae in
Barrett‘s oesophagus
Duplicated muscularis mucosae in
Barrett‘s oesophagus
Smoothelin
Duplicated muscularis mucosae in
Barrett‘s oesophagus
• superficial/new
muscularis mucosae
• new layer of lamina
propria
• deep/true muscularis
mucosae
Vieth M et al. Histological analysisof endoscopic resection specimens from 326 patients
with Barretts‘s esophagus and earyl neoplasia. Endoscopy 2004; 36: 776-81
Duplicated muscularis mucosae in Barrett‘s oesophagus
Vessels in true submucosaVessels in new layer between layers of
duplicated muscularis mucosae
Staging tumors with duplicated
muscularis mucosae
Vieth M et al. Histological analysis of endoscopic resection specimens from 326 patients with Barretts‘s
esophagus and earyl neoplasia. Endoscopy 2004; 36: 776-81
6. PROGNOSIS and TREATMENT
Prognosis of oesophageal carcinoma
Stein HJ et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors
for long-term survival after surgical resection. Ann Surg 2005; 242: 566-73
Clinical behaviour in early oesophageal
carcinoma
SCC:
• nodal metastases in 10% of M3 tumors, and 50% of submucosal tumors (SM1-SM3)
• rarey diagnosed in M1 and M2 stage
Adenocarcinoma:
• no nodal metastases in M1-M3 tumors
• nodal metastases in 10% of SM1 tumors and in 35% of SM3 tumors
Therapy of early oesophageal carcinoma
Radical surgery:
• significant morbidity and mortality �
• removal of lymph nodes ☺
Endoscopic resection:
• less morbidity, negligible mortality ☺
• incomplete removal �
• continuous endoscopic surveillance!
Low-risk group:
• well- or moderately differentiated carcinoma
• no lymphovascular invasion
• mucosal carcinoma (M1-M3)
• less than 2 cm
High-risk group:
• poorly differentiated carcinoma
• lymphovascular invasion
• submucosal invasion (SM1-SM3)
• larger than 2 cm
Risk stratification in early Barrett‘s adenocarcinoma
Endoscopic mucosal resection for early
carcinoma in Barett‘s oesophagus
Handling endoscopic mucosal resection
specimens
• resected en bloc
• oriented
• pinned on cork or styrofoam
• mark deep (!) and lateral margins
• deep margin more important
• serial sections
Conclusions
• Differences between SCC and adenocarcinoma
• In adenocarcinoma, lymphatic spread occurs
later and less frequently.
• SCC rarely diagnosed in early stage – radical
surgery needed in the majority of patients
• Intramucosal adenocarcinoma suitable for
endoscopic resection
• Important correct histopathologic examination
of EMR specimens
Thank you for your attention!